Impact of the Training of Nursing Staff on the Practice of Manual Expression of Early Colostrum in Neonatal Medicine (ORLIKID)

Colostrum is an irreplaceable nutrient rich in protein and antibodies. Its taste and smell are similar to those of amniotic fluid (therefore rich for the senses of the baby separated from his mother). It should be offered to every newborn baby, regardless of term and the type of breastfeeding their mom wants. The early expression of colostrum, within the first 2 hours after childbirth, is an essential way to start lactation of a mother separated from her baby. The sooner and more often the mother stimulates her breasts, the more milk she will have for her baby in the weeks to come. Manual expression of milk is therefore an essential gesture to initiate lactation, maintain it, and giving colostrum to babies as early as possible is beneficial. Two studies carried out in the neonatal medicine department of Felix Guyon Hospital in premature infants <33 week of amenorrhea (PRE'OLACT study in 2015-2016 by Dr RAJAOFERA and Diploma from university (DU) breastfeeding brief in 2018-2019 by Dr GRONDARD) found the same results: the desire for breastfeeding is 80% but manual expression of colostrum before H24 is only achieved by 30% of mothers and before H6 in only 6% of cases.

.

Study Overview

• Status: Completed
• Conditions: Early Breastfeeding
• Intervention / Treatment: Other: Nurses training

• Study Type: Observational
• Enrollment (Actual): 82

Contacts and Locations

• Study Contact: Name: Emilie Techer; Phone Number: 02.62.90.62.83; Email: emilie.techer@chu-reunion.fr
• Study Contact Backup: Name: Claire BRAYER; Phone Number: 02.62.90.58.30; Email: claire.brayer@chu-reunion.fr

Study Locations

• France
  • Saint-Denis, France, 97400
    • Centre hospitalier universitaire de la Réunion

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

All mothers, over 18 years of age, of newborns hospitalized in neonatal medicine at the CHU - Félix GUYON .

Description

Inclusion Criteria:

• All mothers, over 18 years of age, of newborns hospitalized in neonatal medicine at the University Hospital Center (CHU) - Félix GUYON Hospital during the study period.
• Expressed no opposition from mothers to their participation and to the use of their data

Exclusion Criteria:

• Outborn
• Mother not hospitalized in the maternity ward of Félix Guyon Hospital
• Prognosis for the child engaged in the first 24 hours
• Difficult oral comprehension
• Medical contraindication to breastfeeding
• Unseen mother <3D

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
mothers informed by untrained nurse
mothers informed by trained nurse	Other: Nurses training; Presentation of the benefits of colostrum and manual expression technique on a slide show and practical workshops for learning the manual expression technique on a fictitious breast.; Presentation to all staff of a service protocol for early colostrum donation.
mothers informed by nurses trained 6 months ago	Other: Nurses training; Presentation of the benefits of colostrum and manual expression technique on a slide show and practical workshops for learning the manual expression technique on a fictitious breast.; Presentation to all staff of a service protocol for early colostrum donation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
104/5000 Percentage of mothers who expressed colostrum before 24hours	24hours after childbirth

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de la Réunion

Study record dates

Study Major Dates

• Study Start (Actual): September 14, 2020
• Primary Completion (Actual): April 21, 2022
• Study Completion (Actual): April 21, 2022

Study Registration Dates

• First Submitted: September 4, 2020
• First Submitted That Met QC Criteria: September 11, 2020
• First Posted (Actual): September 14, 2020

Study Record Updates

• Last Update Posted (Actual): September 29, 2023
• Last Update Submitted That Met QC Criteria: September 28, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: 2020/CHU/26

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No